Department of Health and Human Services, Laboratory of Kidney and Electrolyte Metabolism, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892-1603, USA.
Proc Natl Acad Sci U S A. 2010 Jan 12;107(2):906-11. doi: 10.1073/pnas.0913415107. Epub 2009 Dec 22.
High NaCl elevates activity of the osmoprotective transcription factor TonEBP/OREBP by increasing its phosphorylation, transactivating activity, and localization to the nucleus. We investigated the possible role in this activation of phospholipase C-gamma1 (PLC-gamma1), which has a predicted binding site at TonEBP/OREBP-phospho-Y143. We find the following. (i) Activation of TonEBP/OREBP transcriptional activity by high NaCl is reduced in PLC-gamma1 null cells and in HEK293 cells in which PLC-gamma1 is knocked down by a specific siRNA. (ii) High NaCl increases phosphorylation of TonEBP/OREBP at Y143. (iii) Wild-type PLC-gamma1 coimmunoprecipitates with wild-type TonEBP/OREBP but not TonEBP/OREBP-Y143A, and the coimmunoprecipitation is increased by high NaCl. (iv) PLC-gamma1 is part of the protein complex that associates with TonEBP/OREBP at its DNA binding site. (v) Knockdown of PLC-gamma1 or overexpression of a PLC-gamma1-SH3 deletion mutant reduces high NaCl-dependent TonEBP/OREBP transactivating activity. (vi) Nuclear localization of PLC-gamma1 is increased by high NaCl. (vii) High NaCl-induced nuclear localization of TonEBP/OREBP is reduced if cells lack PLC-gamma1, if PLC-gamma1 mutated in its SH2C domain is overexpressed, or if Y143 in TonEBP/OREBP is mutated to alanine. (viii) Expression of recombinant PLC-gamma1 restores nuclear localization of wild-type TonEBP/OREBP in PLC-gamma1 null cells but not of TonEBP/OREBP-Y143A. (ix) The PLC-gamma1 phospholipase inhibitor U72133 inhibits nuclear localization of TonEBP/OREBP but not the increase of its transactivating activity. We conclude that, when NaCl is elevated, TonEBP/OREBP becomes phosphorylated at Y143, resulting in binding of PLC-gamma1 to that site, which contributes to TonEBP/OREBP transcriptional activity, transactivating activity, and nuclear localization.
高浓度 NaCl 通过增加其磷酸化、转录激活活性和向核内定位来提高渗透保护转录因子 TonEBP/OREBP 的活性。我们研究了 PLC-γ1(预测在 TonEBP/OREBP-磷酸化 Y143 处具有结合位点)在这种激活中的可能作用。我们发现:(i)高浓度 NaCl 激活 TonEBP/OREBP 的转录活性在 PLC-γ1 缺失细胞和用特定 siRNA 敲低 PLC-γ1 的 HEK293 细胞中降低;(ii)高浓度 NaCl 增加 TonEBP/OREBP 磷酸化 Y143;(iii)野生型 PLC-γ1 与野生型 TonEBP/OREBP 共免疫沉淀,但不与 TonEBP/OREBP-Y143A 共免疫沉淀,高浓度 NaCl 可增加共免疫沉淀;(iv)PLC-γ1 是与 TonEBP/OREBP 在其 DNA 结合位点结合的蛋白质复合物的一部分;(v)敲低 PLC-γ1 或过表达 PLC-γ1-SH3 缺失突变体降低高浓度 NaCl 依赖的 TonEBP/OREBP 转录激活活性;(vi)高浓度 NaCl 增加 PLC-γ1 的核内定位;(vii)如果细胞缺乏 PLC-γ1、过表达突变其 SH2C 结构域的 PLC-γ1 或突变 TonEBP/OREBP 的 Y143 为丙氨酸,则高浓度 NaCl 诱导的 TonEBP/OREBP 核内定位减少;(viii)表达重组 PLC-γ1 恢复 PLC-γ1 缺失细胞中野生型 TonEBP/OREBP 的核内定位,但不能恢复 TonEBP/OREBP-Y143A 的核内定位;(ix)PLC-γ1 磷酸酶抑制剂 U72133 抑制 TonEBP/OREBP 的核内定位,但不增加其转录激活活性。我们的结论是,当 NaCl 升高时,TonEBP/OREBP 在 Y143 处磷酸化,导致 PLC-γ1 与该位点结合,这有助于 TonEBP/OREBP 的转录活性、转录激活活性和核内定位。